Malignant mixed Mtillerian tumor with heterologous component arising in the fallopian tube - a case report

Primary malignant mixed Müllerian tumors (MMMTs) of the fallopian tube are rarities in gynecologic oncology with only 26 cases of MMMTs with a heterologous component reported thus far. We report a case of FIGO Stage II primary MMMT of the fallopian tube with a heterologous tumor portion in an 80-year-old woman presenting with abdominal discomfort at the time of primary diagnosis. After performance of total abdominal hysterectomy, bilateral salpingo-oophorectomy and omentectomy follow-up examination three months postoperatively did not show signs of disease recurrence. The patient finally presented six months after the initial diagnosis with extensive intraabdominal metastasis and died several days thereafter. The present report supports the aggressive nature of these neoplasms. The efficacy of chemotherapy and radiation remains to be defined in future studies.

Malignant mixed Muellerian tumor; Fallopian tube; Histogenesis

[1] Humble S., Carter E.: "Pathologic quiz case: a right adnexal mass in a postmenopausal patient. Malignant mixed mullerian tumor with heterologous elements arising in the fallopian tube". Arch Pathol. Lab. Med., 2004, 128, 161.

[2] Lim BJ., Kim J.W., Yang W.I., Cho N.H.: "Malignant mixed mullerian tumor of fallopian tube with multiple distinct heterologous components". Int. J. Gynecol. Cancer, 2004, 14, 690.

[3] Imachi M., Tsukamoto N., Shigematsu T., Watanabe T., Uehira K., Amada S. et al.: "Malignant mixed Mullerian tumor of the fall opian tube: report of two cases and review of literature". Gynecol Oneal., 1992, 47, 114.

[4] Maitra R.N., Lee J., McConnell D.T., Kenwright D.N., Dady P "Malignant mixed mullerian tumour of the fallopian tube occurring in a patient with Peutz-Jegher's syndrome". Aust. N.Z.J. Obstet. Gynaecol., 2004, 44, 77.

[5] Kuroda N., Moriki T., Oguri H., Maeda N., Toi M., Miyazaki E., et al.: "Malignant mullerian mixed tumor (carcinosarcoma) of the fallopian tube: an immunohistochemical study of neoplastic cells". Apmis, 2005, 113, 643.

[6] Horn L.C., Werschnik C., Bilek K., Emmert C.: "Diagnosis and clinical management in malignant Mullerian tumors of the fallopian tube. A report of four cases and review of recent literature" Arch. Gynecol. Ohstet., 1996, 258, 47.

[7] Costa M.J., Guinee D. Jr.: "CD34 immunohistochemistry in female genital tract carcinosarcoma (malignant mixed mullerian tumors) supports a dominant role of the carcinomatous component". Appl. Immunohistochem. Mol. Morphol., 2000, 8, 293.

[8] Shen D.H., Khoo U.S., Xue W.C., Ngan H.Y., Wang J.L., Liu V.W. et al.: "Primary peritoneal malignant mixed Mullerian tumors. A clinicopathologic, immunohistochemical, and genetic study" Cancer, 2001, 91, 1052.

[9] Gagner J.P., Mittal K.: "Malignant mixed Mullerian tumor of the fimbriated end of the fallopian tube: origin as an intraepithelial carcinoma". Gynecol. Oncol., 2005, 97, 219.

[10] Fujii H., Yoshida M., Gong Z.X., Matsumoto T., Hamano Y., Fuku naga M. et al.: "Frequent genetic heterogeneity in the clonal evolution of gynecological carcinosarcoma and its influence on phenotypic diversity". Cancer Res., 2000, 60, 114.

[11] Emoto M., Iwasaki H., Kikuchi M., Shirakawa K.: "Characteristics of cloned cells of mixed mullerian tumor of the human uterus. Carcinoma cells showing myogenic differentiation in vitro". Cancer, 1993, 71, 3065.

[12] Gorai I., Yanagibashi T., Taki A., Udagawa K., Miyagi E., Nakazawa T. et al.: "Uterine carcinosarcoma is derived from a single stem cell: an in vitro study". Int. J. Cancer, 1997, 72, 821.

[13] Zelmanowicz A., Hildesheim A., Sherman M.E., Sturgeon S.R., Kurman R.J., Barrett R.J. et al.: "Evidence for a common etiology for endometrial carcinomas and malignant mixed mullerian tumors". Gynecol. Oneal., 1998, 69, 253.